Desmopressin NASAL SPRAYS (DDAVP, Stimate, etc) are no longer approved for bedwetting

January 2008

See updated information on this topic from Health Canada

Desmopressin NASAL SPRAYS (DDAVP, Stimate, etc) are no longer approved for bedwetting...due to reports of serious hyponatremia (low blood sodium levels).

Desmopressin works so potently to decrease urine production that it can sometimes lead to water intoxication and low sodium.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

New rules will help clarify Medicare Part D billing for Zostavax (zoster vaccine)
OTC Products Cetirizine (Zyrtec, Zyrtec-D) will soon be available OTC
OTC Products alternatives to traditional OTC cough and cold medicines for infants and young children
Psychiatry Abilify (aripiprazole) Rxs will now require a MedGuide
Infectious Diseases infections that can be passed between humans and their pets
Neurology & Pain Voltaren Gel and Flector Patch will be the first TOPICAL Rx NSAIDs to be commercially available for pain
Diabetes The new Symlin (pramlintide) pen will help reduce errors
Alcohol whether they can drink alcohol with their medications
Respiratory & Allergy Many patients are getting both Spiriva and ipratropium (Atrovent, etc) together
Diabetes & Endocrinology Desmopressin NASAL SPRAYS (DDAVP, Stimate, etc) are no longer approved for bedwetting
Supplements garlic is NOT likely to lower cholesterol
Controlled Substances The DEA now allows prescribers to write multiple C-II Rxs on the same day, for the same patient and drug

Desmopressin NASAL SPRAYS (DDAVP, Stimate, etc) are no longer approved for bedwetting

Practical advice for a better career, with unlimited access to CE

Table of Contents